{"id":358711,"date":"2025-08-20T06:06:11","date_gmt":"2025-08-20T06:06:11","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/358711\/"},"modified":"2025-08-20T06:06:11","modified_gmt":"2025-08-20T06:06:11","slug":"bristol-nhs-merger-could-create-major-health-organisation","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/358711\/","title":{"rendered":"Bristol NHS merger could create major health organisation"},"content":{"rendered":"<p class=\"ssrcss-1q0x1qg-Paragraph e1jhz7w10\">The merger is also improving collaborations in research, including a potential cure for the rare kidney disease, <a href=\"https:\/\/www.kidneyresearchuk.org\/conditions-symptoms\/iga-nephropathy\/\" class=\"ssrcss-f6h2dj-InlineLink e1kn3p7n0\" target=\"_blank\" rel=\"noopener\">IgA nephropathy, external<\/a>.<\/p>\n<p class=\"ssrcss-1q0x1qg-Paragraph e1jhz7w10\">Professor of paediatric nephrology at the University Hospitals Bristol, Moin Saleem,  is teaming up with clinicians from Southmead to start a world-first study using gene therapy, which uses a virus to introduce genetic material into the IgA cell to cure them of the disease.<\/p>\n<p class=\"ssrcss-1q0x1qg-Paragraph e1jhz7w10\">&#8220;The significance we hope will be pretty huge because at the moment there is no curative therapy for this disease,&#8221; said Prof Saleem.<\/p>\n<p class=\"ssrcss-1q0x1qg-Paragraph e1jhz7w10\">&#8220;If this switches off the disease then those patients will be able to avoid dialyses completely.&#8221;<\/p>\n<p class=\"ssrcss-1q0x1qg-Paragraph e1jhz7w10\">Richard Betteridge has IgA nephropathy and hopes to go on the trial. <\/p>\n<p class=\"ssrcss-1q0x1qg-Paragraph e1jhz7w10\">The 32-year-old said: &#8220;It really does give you that sense of hope that there&#8217;s something you can do, and you are also contributing to advancing the science around the management of this condition.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"The merger is also improving collaborations in research, including a potential cure for the rare kidney disease, IgA&hellip;\n","protected":false},"author":2,"featured_media":358712,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4316],"tags":[105,4348,16,15],"class_list":{"0":"post-358711","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-health","9":"tag-healthcare","10":"tag-uk","11":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115059594742159330","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/358711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=358711"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/358711\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/358712"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=358711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=358711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=358711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}